Pfizer’s hemophilia trial cure shows 92% cut in bleeds
Pfizer’s hemophilia trial cure shows a 92% cut in bleeds HQ Team May 30, 2023: Pfizer Inc.’s phase III experimental therapy for treating
HQ Team May 30, 2023: Hunger is set to increase in severity and magnitude in 18 global hotspots out of 22 designated nations,
"Social interactions create a sense of community, reciprocity, and trustworthiness, which are factors positively related to mental well-being and protective against depression."
Neuralink hopes to use its microchips to treat conditions such as paralysis and blindness, and to help certain disabled people use computers and
INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as
Some people continue to suffer from the underlying effects of COVID-19, which manifests in the form of poor health. People suffer from anxiety
Qcells has so far succeeded in developing a tandem perovskite solar cell with a 29.3 per cent efficiency,
• Study subjects with cardiovascular disease who took a daily multivitamin saw the greatest improvement in cognition.